Barclays’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.44M | Hold |
5,288
| – | – | ﹤0.01% | 2804 |
|
|
2026
Q2 | $1.31M | Hold |
5,288
| – | – | ﹤0.01% | 2631 |
|
|
2026
Q1 | $1.06M | Buy |
+5,288
| New | +$1.09M | ﹤0.01% | 2721 |
|
|
2025
Q4 | – | Sell |
-5,288
| Closed | -$948K | – | 5373 |
|
|
2025
Q3 | $948K | Buy |
+5,288
| New | +$901K | ﹤0.01% | 3398 |
|
|
2023
Q2 | – | Sell |
-72
| Closed | -$11.2K | – | 4704 |
|
|
2023
Q1 | $11.2K | Hold |
72
| – | – | ﹤0.01% | 4741 |
|
|
2022
Q4 | $11.1K | Hold |
72
| – | – | ﹤0.01% | 4912 |
|
|
2022
Q3 | $10K | Hold |
72
| – | – | ﹤0.01% | 4295 |
|
|
2022
Q2 | $10K | Hold |
72
| – | – | ﹤0.01% | 4623 |
|
|
2022
Q1 | $11K | Hold |
72
| – | – | ﹤0.01% | 4583 |
|
|
2021
Q4 | $12K | Hold |
72
| – | – | ﹤0.01% | 3984 |
|
|
2021
Q3 | $12K | Hold |
72
| – | – | ﹤0.01% | 4492 |
|
|
2021
Q2 | $12K | Hold |
72
| – | – | ﹤0.01% | 4592 |
|
|
2021
Q1 | $12K | Hold |
72
| – | – | ﹤0.01% | 4420 |
|
|
2020
Q4 | $12K | Hold |
72
| – | – | ﹤0.01% | 4734 |
|
|
2020
Q3 | $11K | Hold |
72
| – | – | ﹤0.01% | 4990 |
|
|
2020
Q2 | $12K | Hold |
72
| – | – | ﹤0.01% | 5301 |
|
|
2020
Q1 | $9K | Sell |
72
-370
| -84% | -$52.7K | ﹤0.01% | 5839 |
|
|
2019
Q4 | $66K | Sell |
442
-69
| -14% | -$9.48K | ﹤0.01% | 5661 |
|
|
2019
Q3 | $63K | Hold |
511
| – | – | ﹤0.01% | 5777 |
|
|
2019
Q2 | $72K | Sell |
511
-67
| -12% | -$9.25K | ﹤0.01% | 5906 |
|
|
2019
Q1 | $87K | Hold |
578
| – | – | ﹤0.01% | 5473 |
|
|
2018
Q4 | $72K | Hold |
578
| – | – | ﹤0.01% | 5256 |
|
|
2018
Q3 | $92K | Sell |
578
-67
| -10% | -$10.1K | ﹤0.01% | 5620 |
|
|
2018
Q2 | $90K | Hold |
645
| – | – | ﹤0.01% | 5314 |
|
|
2018
Q1 | $86K | Hold |
645
| – | – | ﹤0.01% | 5487 |
|
|
2017
Q4 | $80K | Hold |
645
| – | – | ﹤0.01% | 5413 |
|
|
2017
Q3 | $80K | Hold |
645
| – | – | ﹤0.01% | 5078 |
|
|
2017
Q2 | $74K | Hold |
645
| – | – | ﹤0.01% | 5113 |
|
|
2017
Q1 | $68K | Hold |
645
| – | – | ﹤0.01% | 5155 |
|
|
2016
Q4 | $59K | Hold |
645
| – | – | ﹤0.01% | 5057 |
|
|
2016
Q3 | $64K | Hold |
645
| – | – | ﹤0.01% | 4830 |
|
|
2016
Q2 | $58K | Buy |
+645
| New | +$59.2K | ﹤0.01% | 4753 |
|
Other funds holding FBT
Barclays's FBT Position: Q3 2026 in Review
Barclays held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2026 at 5,288 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2804.
Barclays first reported a position in FBT in Q2 2016 and has held it in 32 quarters since. 236 funds tracked by Wall St. Rank hold FBT as of Q3 2026.
- Barclays held 5,288 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.44M as of Q3 2026.
- Barclays left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2026.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2804 holding.
- Barclays first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2016 and has held it in 32 quarters since.
- 236 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.